SynthesisFrontiers in medicine2026
The association between obstructive sleep apnea syndrome and sarcopenia: a meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sleep-disordered breathing as a risk factor for sarcopenia in the elderly: a narrative review.Sleep & breathing = Schlaf & Atmung · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea syndrome (OSAS) and sarcopenia are prevalent conditions associated with aging and metabolic disorders. Emerging evidence suggests a potential link between intermittent hypoxia and skeletal muscle impairment, but findings remain inconsistent. We conducted a meta-analysis to clarify the association between OSAS and sarcopenia in adults. Methods: PubMed, Embase, Web of Science, Wanfang, and CNKI were searched for observational studies evaluating the association between OSAS and sarcopenia in adults. Odds ratios (ORs) with 95% confidence intervals (CIs) were pooled using random-effects models by incorporating the influence of potential heterogeneity. Subgroup and sensitivity analyses were performed to explore heterogeneity. Results: Eight cross-sectional studies comprising 13,331 participants (3,572 with OSAS) were included. Overall, OSAS was significantly associated with sarcopenia (OR 1.85, 95% CI 1.30-2.63; Conclusion: OSAS is associated with increased odds of sarcopenia in adults, particularly in older and Asian populations and in studies using objective sleep assessment. However, given that all included studies were cross-sectional and that diagnostic criteria for both OSAS and sarcopenia varied across studies, these findings should be interpreted cautiously and do not imply causality. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420261324247.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.